Inventage Lab is a clinical-stage company developing high-quality biopharmaceuticals based on its proprietary microfluidics-based drug delivery system (DDS) platforms:

DrugFluidic® enables the development of long-acting injectable formulations for small molecules and peptides, achieving sustained release from 1 to 3 months.

GeneFluidic® is designed for nucleic acid delivery, particularly mRNA, utilizing lipid nanoparticles (LNPs) and incorporates internally developed microfluidics manufacturing equipment.